Tomorrow.bio patients are kept in the European Biostasis Foundation's underground facility, built for long-term stability and security.
Switzerland is politically, financially and socially the most stable country in Europe, which is why the facility is there.
Swiss rules on foundations are among the strictest in the world: the purpose is hard to change, and oversight is constant.
The site sits high above sea level, outside earthquake zones, with minimal risk of natural disaster.
Growth and long-term stability need different structures, so we separated them. Each organisation owns one part of the promise.
There is no time limit to how long you can be cryopreserved for, both from a biological and a financial standpoint. The majority of cryopreservation funds go to a patient care trust called the Tomorrow Patient Foundation (TPF). The TPF puts the funds into very low risk investments that yield 1-2% above inflation every year. This return is more than enough to pay for the running costs of keeping patients cryopreserved. With this system, our patients can remain in cryopreservation for however long it takes until future medical technology can treat them. This is the same system that has been used to successfully keep patients cryopreserved in the US for over 50 years, despite multiple financial crises.
All funds for the cryopreservation procedure and indefinite long-term storage of a patient must be available (via life insurance, etc.) at the time of their legal death. Nothing is paid after a patient is in cryopreservation. Our plans already include all the funds needed for indefinite long-term storage.
Nothing. Cryopreservation is maintained by liquid nitrogen alone, with no electricity involved, so patients are unaffected by a power outage.
For safety reasons the facility is not open to visitors. Members are invited to an annual event held at the facility.
Our cryopreservation plans were carefully constructed with the long-term security of patients in mind, so they would be unaffected if Tomorrow were to cease operations. Tomorrow’s cryopreserved patients are stored at the European Biostasis Foundation (EBF) in Switzerland. EBF is a non-profit organization with complete financial independence. The funds to keep patients cryopreserved are managed by a patient care trust which is a non-profit private benefit organization. This means that cryopreserved patients would not be affected if Tomorrow ever ceased its operations.
The European Biostasis Foundation (EBF) is a Swiss non-profit organization which means it's subject to more strict governmental oversight than non-profit's in most other countries. Specifically, the Swiss government ensures that non-profit's stay mission aligned and do not change from the purpose for which they were founded. This means that EBF must stay true to it's mission to advance Biostasis science and provide secure long-term storage. Additionally, EBF's statutes and bylaws are optimized for long-term stability (i.e. vote quorums, self amending board). EBF is entirely financially independent from Tomorrow Bio and receives regular generous donations for its research endeavours. All members of the board of EBF are highly intrinsically motivated with a long-term involvement in the field and receive no financial incentive for their board position.
People involved in the management of the Tomorrow Patient Foundation (TPF) must be signed up for cryopreservation and/or have loved ones currently in cryopreservation. Additionally, members of the TPF receive no financial compensation which means the organization has no overhead costs and only attracts people who are highly intrinsically motivated to keep our cryopreserved patient stable and secure.
When you’re traveling for a longer period outside of our core regions (3 weeks or more), please get in touch with us so that we can organize a partner organization to handle standby (subject to availability).
